139297-28-2 Usage
General Description
The chemical {3-[(2,6-dimethylphenyl)carbamoyl]isoxazol-5-yl}methyl carbamate is a compound with the molecular formula C15H18N2O4. It is a carbamate derivative that contains an isoxazole ring and a methyl carbamate group. {3-[(2,6-dimethylphenyl)carbamoyl]isoxazol-5-yl}methyl carbamate is commonly used as a pesticide or insecticide due to its ability to control pests and insects by disrupting their central nervous system. Additionally, it has potential application in the medical field due to its anticonvulsant and anti-inflammatory properties. However, it is important to handle and use this chemical with caution, as it can be harmful if ingested or inhaled and may cause irritation to the skin and eyes.
Check Digit Verification of cas no
The CAS Registry Mumber 139297-28-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,2,9 and 7 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 139297-28:
(8*1)+(7*3)+(6*9)+(5*2)+(4*9)+(3*7)+(2*2)+(1*8)=162
162 % 10 = 2
So 139297-28-2 is a valid CAS Registry Number.
139297-28-2Relevant articles and documents
New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents
Lepage,Tombret,Cuvier,Marivain,Gillardin
, p. 581 - 593 (2007/10/02)
We prepared a series of N-aryl isoxazolecarboxamide, N-isoxazolylbenzamide compounds and derivatives and studied their anticonvulsant action in MES and MMS tests. Some of these reveal considerable activity, especially with respect to MES test. The disubstitution in the 2.6-position on the phenyl ring by two methyl groups would appear to be of primary importance for the activity. The amide bridge between the phenyl and isoxazolic rings, whether of the anilide or benzamide type, seems to show similar anticonvulsant behavior. We have selected the derivatives 8 (N-(2.6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide, 12 (N-(2.6-dimethylphenyl)-5-hydroxymethyl-3-isoxazolecarboxamide) and 51 (N-(5-methyl-3-isoxazolyl)-2.6-dimethylbenzamide) which are presently being studied in more extended pharmacological tests.